Consult
Log In
Menu
Consult
Log in

by PierianDx, on September 13, 2018

Precision medicine is the ability to use genomic information to optimize diagnosis and treatment and provide better outcomes for patients. We Know Precision Medicine is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In honor of childhood cancer awareness month, Lisa Owen, Marketing Director, discusses her role at PierianDx and why precision medicine is so important to her.

Read Story
Topics:Blog

by Michael L. Sanderson, on September 4, 2018

In many healthcare settings the important role of pathology is underestimated and misunderstood. Likely, we can thank TV crime shows for the public perception that pathologists only perform autopsies and complicated analyses that help catch bad guys.

Read Story
Topics:Blog

by PierianDx, on August 29, 2018

Are you considering offering clinical NGS testing or looking for an economical approach to building your program? 

Read Story
Topics:Blog

by PierianDx, on August 24, 2018

We Know Precision Medicine is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this article, Shalini Verma, Laboratory and Medical Director, discusses her role at PierianDx and how our products and services will help make precision medicine a routine component of healthcare.  

Read Story
Topics:Blog

by PierianDx, on August 14, 2018

Recently we hosted a webinar in which Medical Director, Shalini Verma, and VP Product, Andy Bredemeyer, reviewed and applied the Association for Molecular Pathology (AMP) joint consensus guidelines for the interpretation and reporting of sequence variants in cancer. 

Read Story
Topics:Blog

by Lisa Owen, on July 26, 2018

"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this article, Andy Bredemeyer, VP Product, discusses how PierianDx has given him the opportunity to impact patient care in a way he never thought possible. 

Read Story
Topics:Blog

by Lisa Owen, on July 13, 2018

Preparing for our upcoming webinar -- A Practice-based Guide for Interpretation and Reporting of Sequence Variants in Cancer--caused us to think about the evolution of next generation sequencing (NGS) into the clinic and how there’s hasn't been a dull moment since this technology was first introduced.

Read Story
Topics:Blog

by PierianDx, on June 27, 2018

"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this first article, Rakesh Nagarajan, Founder and Executive Chairman, discusses the origin of PierianDx and why he has devoted his life to make precision medicine a reality.

Read Story
Topics:Blog

by PierianDx, on April 19, 2018

In the U.S. alone, there are nearly 700,000 people living with a primary brain tumor. And each year, there are nearly 70,000 new diagnoses and 17,000 deaths. [1]  With over 120 different types of tumors and a tricky blood-brain barrier to permeate, brain tumors are notoriously difficult to treat, and the standard of care hasn’t changed in many years. More than any other type of cancer, brain tumor survivors face motor, cognitive, and psychological challenges.

Read Story
Topics:Blog